Candel Therapeutics Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$10.85

-0.49 (-4.32%)

As of Sep 20, 10:33 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 13 87%

Hold 2 13%

Sell 0 0%

Price Target

Analyst Price Target +338.6% upside

Low Target $33.44

Average Target $47.59

High Target $47.92

Current Price $10.85

Current
$10.85

Target
$47.59

$33.44 $47.59 avg $47.92

Scenario Analysis

Bear Case

$33.44

208.2%

Low target

Base Case

$47.59

+338.6%

Avg target

Bull Case

$47.92

+341.7%

High target

Risk/Reward

1.6x

Balanced

Price in Context

52-Week High

$14.00

-22.5% from high

52-Week Low

$4.35

+149.4% from low

Target vs 52W High

$47.59

+239.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.9%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.1%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%